Results 121 to 130 of about 7,708 (214)

Does persistent hyperprolactinemia contribute to bone loss independently of estrogen deficiency in postmenopausal women? [PDF]

Pituitary
Tunc A, Muradov I, Capar MU, Kocaman BB, Farajli M, Yogurtcu S, Baykal OA, Taze SS, Durcan E, Sahin S, Ozkaya HM, Kadioglu P.   +11 more
europepmc   +1 more source

Concurrent human epidermal growth factor receptor 2-positive breast cancer with axillary nodal metastasis in a patient with pituitary prolactinoma: a case report. [PDF]

AME Case Rep
Duan JF, Li T, Zhang QJ, Lu JH.
europepmc   +1 more source

Central serous chorioretinopathy following intramuscular testosterone therapy in prolactinoma. [PDF]

Oxf Med Case Reports
Jha V, Dutta P, Grossman AB, Bashyal B.
europepmc   +1 more source

<i>Blautia</i>-PTGS1 co-occurrence in prolactinomas: potential implications for tumor microenvironment and invasiveness. [PDF]

J Endocr Soc
Ye Z, Yang J, Ji L, Han R, Yu Y, Ye Z, Gu X, Cai B, Ji C, Qiao N, Chen Z, Ma Z, Chen L, Liao Y, Shi C, He W, Cao X, Zhou X, Shou X, Wang Y, Zhang Z, Ye H, Zhang Y, Zhang Q.   +23 more
europepmc   +1 more source

Chinese consensus on the diagnosis and treatment of prolactinomas (2025 edition). [PDF]

Chin Neurosurg J
Lin S, Chen Z, Ji L, Wang L, Zhang W, Tang X, Wu Y, Fan Q, Li J, Pan L, Yao Z, Deng C, Ye H, Li S, Zhu H, Zhao Y, Wang Y, Wu ZB, China Pituitary Adenoma Specialist Council.   +18 more
europepmc   +1 more source

Long-term survival in glioblastoma patients treated with dopamine agonists: A report of two cases and implications for drug repurposing. [PDF]

Surg Neurol Int
Oxman L, Laviv Y.
europepmc   +1 more source

Multimodal management of giant prolactinoma with extensive amyloid spherule deposition: a case report with review of the literature. [PDF]

Endocr J
Unver Ozkahraman A, Korkmaz Yilmaz M, Karatay H, Bagbudar S, Akpinar E, Erkan B, Karagulle M, Yilmaz M, Niyazoglu M, Hatipoglu E.   +9 more
europepmc   +1 more source

Recurrent nasal bleed as initial presenting complaint: a rare complication of giant prolactinoma in a 39-year-old. [PDF]

Ann Med Surg (Lond)
Fahim W, Kamin M, Sultan L, Sabir B, Iqbal MU, Hajj F.   +5 more
europepmc   +1 more source

Editorial: Discovery of small molecule lead compounds: a driving force to unravel new anti-cancer targets and mechanisms, volume III. [PDF]

Front Oncol
Zhang Y, Fu L, Wang Y.
europepmc   +1 more source

Prolactinoma in males: a single center experience in Northern Africa. [PDF]

Med Pharm Rep
El Yamani N, Jamal A, Bouichrat N, Rouf S, Latrech H.   +4 more
europepmc   +1 more source